Summary : The Food and Drug Administration (FDA) has approved a novel first-in-class drug to treat type 2 diabetes. The drug is…
Eli Lilly
-
-
CompaniesEli Lilly
ImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 Billion
by adminby adminSynopsis : ImmunoGen Inc., a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, announced a global,…
-
CompaniesEli LillyRegulatoryU.S FDA
Lilly’s bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19
by adminby adminSummary : The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates…
-
CompaniesEli LillyGlobal Market
Lilly Says Safety Not A Factor In Dropping Lupus Development With Olumiant
by adminby adminExecutive Summary The pharma also warns that an FDA complete response letter could be coming for its supplemental NDA to add atopic…
-
CompaniesEli Lilly
JPM 2022: Eli Lilly gears up for Alzheimer’s-diabetes juggling act as 2 key FDA decisions loom
by adminby adminSummary : On the brink of two major approvals this year, Eli Lilly is laser-focused on diabetes and dementia. One market is…
-
Synopsis – – Vineet Gupta joined Eli Lilly in 2010 as Marketing Director for India, followed by a role as Corporate Affairs…
-
Synopsis: The FDA’s authorization expands the drug’s use to fight Covid-19 to people under the age of 12 The therapy, Bamlanivimab plus…